Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00334711
Status:
COMPLETED
Last Update Posted:
2006-11-29
First Post:
2006-06-07
Brief Title:
Sulfonylurea Response in Patients With Diabetes Due to Kir62 Mutations
Sponsor:
Royal Devon and Exeter NHS Foundation Trust
Organization:
Royal Devon and Exeter NHS Foundation Trust
Study Overview
Official Title:
A Prospective Study of Sulfonylureas in Patients With Diabetes Due to Kir62 Mutations
Status:
COMPLETED
Status Verified Date:
2006-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate whether patients with diabetes due to Kir62 mutations can be treated with sulfonylurea medication rather than insulin and if this is the case to investigate the mechanism for sulfonylurea response
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 9729AHmbs NTNU | None | None | None |
| Jnr 207mkd NTNU | None | None | None |
| CCPPRB Necker GLIDKIR62 | None | None | None |